Smruti K. Patel · Supramaximal Resection in Glioblastoma: Expanding Surgical Boundaries in the Era of Precision Neuro-Oncology-A Systematic Review
Follow
Article1 min read·Published Apr 2026

Supramaximal Resection in Glioblastoma: Expanding Surgical Boundaries in the Era of Precision Neuro-Oncology-A Systematic Review

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Apr 2026 · 1 min read

In brief

In brief

This systematic review examines supramaximal resection (SMR) in glioblastoma—a surgical approach extending beyond traditional contrast-enhancing margins using advanced imaging and fluorescence guidance. Analysis of 37 studies suggests SMR may improve survival in selected patients, though standardization challenges limit widespread adoption.

Written by the GCMD Library team from the article.

Smruti K. Patel

Background: Glioblastoma remains the most aggressive and treatment-resistant primary brain tumor, with patient outcomes strongly associated with the extent of surgical resection. Tumor recurrence is largely driven by infiltrating glioma cells that extend beyond the contrast-enhancing margin, which has traditionally served as the boundary for surgical resection. Advances in pre- and intraoperative imaging, functional mapping, and fluorescence guidance have challenged the conventional definition of "maximal safe resection" and given rise to the concept of supramaximal resection (SMR). This technique, where surgical resection extends beyond the contrast-enhancing border, has garnered significant interest in recent years and shown promising preliminary survival outcomes. However, the lack of standardized definitions and methodological consistency has limited reproducibility and clinical adoption. Methods: A systematic literature search of PubMed/MEDLINE, Embase, and Web of Science was performed from database inception through March 2026 in accordance with PRISMA guidelines. Studies investigating resection beyond the contrast-enhancing tumor margin in adult glioblastoma patients were evaluated for inclusion. Results: A total of 1045 records were identified, with 37 studies meeting inclusion criteria. Across studies, SMR was frequently associated with improved progression-free and overall survival in selected patients, particularly following complete contrast-enhancing tumor resect

Statements in this article

  1. Glioblastoma remains the most aggressive and treatment-resistant primary brain tumor, with patient outcomes strongly associated with the extent of surgical resection.

    EstablishedBackground
  2. Tumor recurrence is largely driven by infiltrating glioma cells that extend beyond the contrast-enhancing margin, which has traditionally served as the boundary for surgical resection.

    EstablishedBackground
  3. Supramaximal resection is defined as surgical resection that extends beyond the contrast-enhancing border.

    EstablishedBackground
  4. The lack of standardized definitions and methodological consistency has limited reproducibility and clinical adoption of supramaximal resection.

    OpenBackground
  5. A total of 1045 records were identified, with 37 studies meeting inclusion criteria for this systematic review.

    ResearchResults
  6. Supramaximal resection was frequently associated with improved progression-free and overall survival in selected patients, particularly following complete contrast-enhancing tumor resection.

    ResearchResults

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
Only a few other public items share this field — go deeper there →
GCMD Library — educational content from recorded physician discussions, not medical advice.